Lonza Announces Completion of New GMP Suite

Lonza, a global leader in the field of biologics manufacturing, today announced the successful completion of its new GMP clean room within its Houston, Texas operations.

The clean room supports multiple types of viral vector and viral vaccine projects, with working volumes up to 2,000 liters.

Lonza announced the launch of this project in May 2011.

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read